LungSpecialist
@LungConsultant
Followers
4K
Following
6K
Media
427
Statuses
2K
Professor Neal Navani MA MSc PhD FRCP, Consultant in Thoracic Medicine @uclh, Professor @uclrespiratory
London, England
Joined April 2012
November is Lung Cancer Awareness Month. Contact your GP practice if you are experiencing any of these signs and symptoms of lung cancer. It’s probably nothing serious, but early diagnosis and treatment can save lives.
3
54
39
.@alexandra_p_24, @LeciaSequist and I wrote a new editorial in JAMA ( https://t.co/bV1KF4bHmc) responding to a powerful #lungcancer screening study by Bandi et al ( https://t.co/AGqM52seY2). In 2024, only 18.7% of adults eligible for #lungcancerscreening in the U.S. were screened.
3
14
30
🫁 Lung Cancer Awareness Month 🫁 As we raise awareness this November, we’re also looking ahead to a key milestone in the lung cancer audit calendar. 📢📅On 12 Feb 2026, NLCA will publish the State of the Nation Report, alongside the Patient and Public Report. @LungConsultant
1
1
0
Prof Neal Navani @LungConsultant explores the epidemiology of non-smoking lung cancer — uncovering trends and insights from global data. #nonsmokinglungcancer
0
1
1
Neal Navani kicks off our Essential Update 👉 Epidemiology of Non-Smoking Lung Cancer 🔺 5th commonest cause of cancer deaths in UK 🔺 ⬆️ Incidence 🔺 May = ⬆️ non-smoking popn, not true increase risk 🔺 Risk factors = sex, ethnicity, pesticides, wood burning, pollution, RhA
1
5
4
‼️ Day -1 until @BTOGORG and @RuthStraussFdn Non-smoking Lung Cancer Essential Update ⭐ Great speakers ⭐ Important topics ⭐ Patient representation ⭐ Big audience Program 👇
0
4
13
Excited to share our new meta-analysis on risk factors for lung cancer in never-smokers! Key factors include female sex, rheumatoid arthritis and pollution. We hope to use this to develop tools to detect such cancers earlier. #lungcancer
https://t.co/MU66wOvJQU
0
4
19
@HQIP @LungConsultant @NATCAN_news @Roy_Castle_Lung @SCTSUK Earlier this year, the National Lung Cancer Audit (NLCA) published a helpful resource: 📘 “Questions to Ask Healthcare Professionals” – designed to support individuals navigating a lung cancer diagnosis and treatment. 🔗 Read it here: https://t.co/b8MAmHsmY8
#LungCancer
natcan.org.uk
Navigating a lung cancer diagnosis and treatment can feel overwhelming. We have put together a list of questions that it might be helpful to ask healthcare professionals involved in your care for...
1
1
0
@HQIP @LungConsultant @NATCAN_news @Roy_Castle_Lung @SCTSUK 🔗 The NLCA Patient and Public Report 2025 shares insights into the experiences of people diagnosed with lung cancer in 2023 across England and Wales: https://t.co/LeDWDueYg6
#LungCancerAwarenessMonth
natcan.org.uk
The NLCA Patient and Public Report 2025 presents the results for patients diagnosed during 2023 in England and Wales. There is also a version of this report for healthcare professionals which can be...
0
1
1
Today marks the start of Lung Cancer Awareness Month. At BTOG, we unite healthcare professionals, researchers, and patients to improve outcomes in thoracic oncology. Together, we can make a difference. #LungCancerAwareness #LCSM #LungCancer
1
7
18
@LungConsultant asks: Are we starting to see the impact of screening within the National Lung Cancer Audit (NLCA)? #BTOGScreeningEvent #LCSM
0
3
3
@HQIP @LungConsultant @NATCAN_news @Roy_Castle_Lung @SCTSUK @BtoG ✨New features: 📥Download report– Choose between Data downloads or Report downloads 📊Data downloads– Access multiple metrics for a single Trust or all Trusts in a Cancer Alliance 🏥Organisation selection– Search and fix your organisation view while switching metrics
0
1
1
The NLCA October quarterly data dashboard is now live! This includes the latest English data up to 31 Dec 2024: https://t.co/C66ardfuLM
@HQIP @LungConsultant @NATCAN_News @Roy_Castle_Lung @SCTSUK @BTOG #LungCancer
1
2
0
This year marks 20 years of the UKLCC! Join us on the 4th November 2025 at Mary Ward House, London, as we celebrate two decades of progress - and set priorities for the next 20 and beyond. ✅ Multidisciplinary ✅ Relevant ✅ Interactive Register 👉 https://t.co/EWQz0cgSE4
1
1
4
📢NLCA has launched a brand new Patient Guide to Statistics📊 This guide is designed to help patients, carers, and the public better understand the numbers and data used by the Audit. Check it out here: https://t.co/7WJOScqDhs
@HQIP
@LungConsultant
@NATCAN_news
@Roy_Castle_Lung
natcan.org.uk
This guide is intended to help patients and the public better understand the numbers and statistics used by the National Lung Cancer Audit to report lung cancer care.
1
4
3
Fantastic to hear this morning that #lungcancer screening has been approved as a national programme in Wales. Come on SCO & NI #lcsm
@UKlungcancer @Roy_Castle_Lung
https://t.co/f3b0KpgELF
gov.wales
Jeremy Miles MS, Cabinet Secretary for Health and Social Care
1
0
15
Fantastic talk by @SalmaJabbour1 on high risk SABR. Highlights that Squamous call lung cancer at higher risk of recurrence post SABR. Also discussed competing causes of mortality, ctDNA and addition of IO 👏🏽👏🏽
0
6
17
Excited to be in Montreal at the ELIXR meeting to learn & discuss the future of early stage NSCLC🍁 Thanks to conference chair @DoctorJSpicer for the invitation to present, & learn/strategize with stellar colleagues @mcgillu @CancerCentreIre #LCSM
1
7
30
Pleasure to discuss this key challenge in #lungcancer care & describe practical steps to optimising biomarker testing & strategic steps to ensure equitable access. With thanks @LungConsultant for leading this and expert colleagues @DrRiyazShah @drasharman
https://t.co/Rik8giFS8L
1
1
9
A reminder for all @myESMO members to vote in this year's election! Am honoured to be standing amongst fantastic colleagues. Make your voice heard! Vote closes: Tuesday, 10 June 2025, 12:00 (noon) CEST https://t.co/Gd0pfW9bvX
#ESMOMembers vote for the leaders who will shape ESMO’s future. Vote now for the Directors of Education, Public Policy & Membership - and the Chair and members of the Nomination Committee 📽️ Watch the ESMO President’s message 🔗 Vote now: https://t.co/8CvlHhzcSI
@FAndreMD
1
3
14